Retrospective study of severe cases of leptospirosis admitted in the intensive care unit

Journal of Postgraduate Medicine

Volumn 53, Issue 4, 2007, Pages 232-235

  Ittyachen, A M ^a   Krishnapillai, T V ^a   Nair, M C ^a   Rajan, A R ^a  

^a MOSC Medical College   (India)

Author keywords

Acute respiratory distress syndrome; Leptospirosis; Thrombocytopenia

Indexed keywords

LIVER ENZYME; METHYLPREDNISOLONE; PENICILLIN G;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; FEMALE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LEPTOSPIROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; RURAL AREA; SURVIVAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 37849046910     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.37510     Document Type: Article

References (28)

1. Bharti AR, Nally JE, Ricalde JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: A zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-71.
2. Terpstra WJ. International leptospirosis Society. Human Leptospirosis: Guidance for diagnosis, surveillance and control. World Health Organization: Geneva; 2003.
3. Kuriakose M, Eapen CK, Paul R. Leptospirosis in Kolenchery, Kerala, India: Epidemiology, prevalent local serogroups and serovars and a new serovar. Eur J Epidemiol 1997;13:691-7.
4. Faine S. Guidelines for the control of Leptospirosis. World Health Organization: Geneva; 1982. WHO offset publication No. 67.
5. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
6. Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Ranoa CP, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988;1:433-5.
7. O'Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis 1991;13:705-9.
8. Martinez Garcia MA, de Diego Damia A, Menendez Villanueva R, López Hontagas JL. Pulmonary involvement in leptospirosis. Eur J Clin Microbiol Infect Dis 2000;19:471-4.
9. Silva JJ, Dalston MO, Carvalho JE, Setubal S, Oliveira JM, Pereira MM. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 2002;35:395-9.
10. Nally JE, Chantranuwat C, Wu XY, Fishbein MC, Pereira MM, Da Silva JJ, et al. Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 2004;164:1115-27.
11. Miller NG, Allen JE, Wilson RB. The pathogenesis of hemorrhage in the lung of the hamster during acute leptospirosis. Med Microbiol Immunol 1974;160:269-78.
12. De Brito T, Bohm GM, Yasuda PH. Vascular damage in acute experimental leptospirosis of the guinea-pig. J Pathol 1979;128:177-82.
13. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-84.
14. Ittyachen AM, Lakshmanakumar VK, Eapen CK, Joseph MR. Methylprednisolone as adjuvant in treatment of acute respiratory distress syndrome owing to leptospirosis: A pilot study. Indian J Crit Care Med 2005;9:133-6.
15. Shenoy VV, Nagar VS, Chowdhury AA, Bhalgat PS, Juvale NI. Pulmonary leptospirosis: An excellent response to bolus methylprednisolone. Postgrad Med J 2006;82:602-6.
16. Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 1999;61:630-4.
17. Sitprija V, Losuwanrak K, Kanjanabuch T. Leptospiral nephropathy. Semin Nephrol 2003;23:42-8.
18. Sitprija V. Overview of tropical nephrology. Semin Nephrol 2003;23:3-11.
19. Visith S, Kearkiat P. Nephropathy in leptospirosis. J Postgrad Med 2005;51:184-8.
20. Sitprija V, Papatanagul V, Mertowidjojo K, Boonpcknavig V, Boonpcknavig S. Pathogenesis of renal disease in leptospirosis: Clinical and experimental studies. Kidney Int 1980;17:827-36.
21. O'Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis 1991;13:705-9.
22. Kahn JB. A case of Weil's disease requiring steroid therapy for thrombocytopenia and bleeding. Am J Trop Med Hyg 1982;31:1213-5.
23. Chang ML, Yang CW, Chen JC, Ho YP, Pan MJ, Lin CH, et al. Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis. World J Gastroenterol 2005;11:5553-6.
24. Edwards CN, Evarard CO. Hyperamylasemia and pancreatitis in leptospirosis. Am J Gastroenterol 1991;86:1665-8.
25. Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Leptospirosis in Barbados: A clinical study. West Indian Med J 1990;39:27-34.
26. de Brito T, Morais CF, Yasuda PH, Lancellotti CP, Hoshino-Shimizu S, Yamashiro E, et al. Cardiovascular involvement in human and experimental leptospirosis: Pathologic findings and immunohistochemical detection of leptospiral antigen. Ann Trop Med Parasitol 1987;81:207-14.
27. Teglia OF, Battagliotti C, Villavicencio RL, Cunha BA. Leptospiral pneumonia. Chest 1995;108:874-5.
28. Hill MK, Sanders CV. Leptospiral pneumonia. Semin Respir Infect 1997;12:44-9.